Valeant Board Urges CEO To Show For Senate Deposition
Embattled drugmaker Valeant Pharmaceuticals International Inc.'s board of directors on Monday urged its outgoing CEO J. Michael Pearson to comply with a Senate subpoena after he failed to show for a...To view the full article, register now.
Already a subscriber? Click here to view full article